Vaccine and treatment evaluation units

Ended Awarded Last action

Contract number
HHSN27200016
Awardee
Awarding agency
Obligated
$3,600,571

Award facts

Opportunity
Contract value 100% obligated
$3,600,570.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Baltimore, MD 21201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 · UMB vaccine treatment evaluation units (vteus) - to 16 -$3,378
Change Order P00007 · The purpose of this modification is to add funds and extend the period of performance for task area d, options 6, 7 and 11.b and update various articles and… $262,361
Other Administrative Action P00006 $0
Other Administrative Action P00005 · Vaccine and treatment evaluation units 15-0066.B1C1D1.0041 $0
Other Administrative Action P00004 $0
Funding Only Action 3 $39,235
Funding Only Action 2 $80,427
Other Administrative Action 1 $0
Original award $3,221,926

About this award

Written by GovTribe AI ·

This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) for the Vaccine and Treatment Evaluation Units (VTEU) program. The award, made on September 20, 2016, has a ceiling value of $3,600,570.60 and an ultimate completion date of August 31, 2021. This is a delivery order contract with a cost-no-fee pricing type. The contract is not set-aside. UMB, a prominent academic health sciences institution, has demonstrated extensive capabilities in providing specialized medical research, clinical services, and laboratory support to federal agencies. As the parent organization, the University System of Maryland has also been awarded federal contracts and grants for various research, educational, and IT initiatives. This VTEU contract supports critical vaccine and treatment evaluation efforts for infectious diseases.

Quick answers

Who was awarded contract HHSN27200016?

HHSN27200016 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 20, 2016.

How much is contract HHSN27200016 worth?

The government has obligated $3,600,571 on HHSN27200016.

Is contract HHSN27200016 an order under another contract?

Yes. HHSN27200016 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200016 competed?

The extent of competition for HHSN27200016 was full and open competition. The government received 7 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login